Generation genome and the opportunities for screening programmes – Public Health England

The report briefly defines genome sequencing and how, by improving our understanding of genetic activity, we can determine how best to use genetics in screening. This report explores how genomic technologies can help us to improve screening programmes, and opportunities

Screening Quality Assurance visit report: NHS Bowel Cancer Screening Programme Harrogate, Leeds and York – Public Health England

Executive summary of quality assurance (QA) visit in Harrogate, Leeds and York held on 18 and 19 March 2019.  

Screening Quality Assurance visit report: NHS Cervical Screening Programme Homerton University Hospital NHS Foundation Trust – Public Health England

Executive summary of quality assurance (QA) visit to Homerton Hospital NHS Foundation Trust held on 1 February 2019.

Screening Quality Assurance visit report: NHS Antenatal and Newborn Screening Programmes Warrington And Halton Hospitals NHS Foundation Trust – Public Health England

Executive summary of quality assurance (QA) visit to Warrington and Halton Hospitals NHS Foundation Trust held on 30 April 2019.  

Screening Quality Assurance visit report: NHS Breast Screening Programme Doncaster Hospitals NHS Foundation Trust – Public Health England

Executive summary of quality assurance (QA) visit to Doncaster Hospitals NHS Foundation Trust held on 5 March 2019.  

Screening Quality Assurance visit report: NHS Antenatal and Newborn Screening Programmes King’s College Hospital NHS Foundation Trust – Public Health England

Executive summary of quality assurance (QA) visit to NHS Antenatal and Newborn Screening Programmes King’s College Hospital NHS Foundation Trust, held on 27 and 28 March 2019.  

Screening Quality Assurance visit report: NHS Cervical Screening Programme Northern Lincolnshire and Goole NHS Foundation Trust – Public Health England

Executive summary of quality assurance (QA) visit to Northern Lincolnshire and Goole NHS Foundation Trust held on 19 and 20 March 2019.

Fixing the present, building for the future: newborn screening for rare conditions – Genetic Alliance UK

This report contains recommendations to adapt decision making to fit rare diseases, to embrace the potential of screening as a rare disease identification system, and to take advantage of developments in technology.

SCT screening data flows to the National Congenital Anomaly and Rare Disease Registration Service – Public Health England

Flowchart showing the sickle cell and thalassaemia (SCT) screening newborn outcomes project pathway. The document includes actions for: babies with a newborn blood spot screen positive result clinical presentation of an affected child or infant

Screening Quality Assurance visit report: NHS Diabetic Eye Screening Programme Doncaster & Bassetlaw – Public Health England

Executive summary of quality assurance (QA) visit to Doncaster & Bassetlaw held on 21 March 2019.  

Screening Quality Assurance visit report: NHS Antenatal and Newborn Screening Programmes George Eliot Hospital NHS Trust – Public Health England

Executive summary of quality assurance (QA) visit to George Eliot Hospital NHS Trust, held on 8 and 9 January 2019.  

Supporting the health system to reduce inequalities in screening: PHE Screening inequalities strategy – Public Health England

The PHE Screening inequalities strategy is aimed at supporting local screening services, commissioners and others involved in the provision of screening to address inequalities.

NHS Breast Screening Programme Equipment Report: Technical Evaluation of IMS Giotto Class digital mammography system in 2D mode – Public Health England

Technical evaluation of the IMS Giotto Class digital mammography system in 2D mode, used in the NHS breast screening programme.  Thisreport is one of a series of technical reports evaluating commercially available mammography systems on behalf of the NHS breast

Protocols for the surveillance of women at higher risk of developing breast cancer: Version 4 – Public Health England

The NHS breast surveillance protocols for women at higher risk of developing breast cancer.  Healthcare professionals working in the NHS breast screening programme should use these protocols.  They apply to women referred to the screening programme with a higher risk of developing

Screening Quality Assurance visit report: NHS Antenatal and Newborn Screening Programmes University Hospitals of Leicester NHS Trust: Executive Summary – Public Health England

Executive summary of quality assurance (QA) visit to University Hospitals of Leicester NHS Trust, held on 29 January 2019.